These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9434874)

  • 41. New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds.
    Golbamaki A; Benfenati E; Golbamaki N; Manganaro A; Merdivan E; Roncaglioni A; Gini G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016 Apr; 34(2):97-113. PubMed ID: 26986491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Concept of tumor promoters in hepatocarcinogenesis].
    Frayssinet C; Lafarge-Frayssinet C
    Bull Cancer; 1990; 77(5):455-9. PubMed ID: 2400816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis.
    van Leeuwen IM; Zonneveld C
    Mutat Res; 2001 Oct; 489(1):17-45. PubMed ID: 11673088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indolo[3,2-b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter.
    Herrmann S; Seidelin M; Bisgaard HC; Vang O
    Carcinogenesis; 2002 Nov; 23(11):1861-8. PubMed ID: 12419834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytochrome P450-mediated metabolism of tumour promoters modifies the inhibition of intercellular communication: a modified assay for tumour promotion.
    Vang O; Wallin H; Doehmer J; Autrup H
    Carcinogenesis; 1993 Nov; 14(11):2365-71. PubMed ID: 8242868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
    Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of rodent carcinogens by an expert system.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro.
    Mascolo MG; Perdichizzi S; Vaccari M; Rotondo F; Zanzi C; Grilli S; Paparella M; Jacobs MN; Colacci A
    Carcinogenesis; 2018 Jul; 39(7):955-967. PubMed ID: 29554273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further characterization of the in vitro assay for inhibitors of metabolic cooperation in the Chinese hamster V79 cell line.
    Jone C; Trosko JE; Aylsworth CF; Parker L; Chang CC
    Carcinogenesis; 1985 Mar; 6(3):361-6. PubMed ID: 3978751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different mechanisms of modulation of gap junction communication by non-genotoxic carcinogens in rat liver in vivo.
    Cowles C; Mally A; Chipman JK
    Toxicology; 2007 Aug; 238(1):49-59. PubMed ID: 17624652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Feb; 228(2):105-24. PubMed ID: 2300064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concordance of transcriptional and apical benchmark dose levels for conazole-induced liver effects in mice.
    Bhat VS; Hester SD; Nesnow S; Eastmond DA
    Toxicol Sci; 2013 Nov; 136(1):205-15. PubMed ID: 23970803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omeprazole: an exploration of its reported genotoxicity.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1991 Sep; 6(5):381-4. PubMed ID: 1795642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of growth state, tumor promoters, and transformation upon intercellular communication between C3H/10T1/2 murine fibroblasts.
    Boreiko CJ; Abernethy DJ; Rickert DE; Stedman DB
    Carcinogenesis; 1989 Jan; 10(1):113-21. PubMed ID: 2910519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical carcinogenicity revisited 1: A unified theory of carcinogenicity based on contemporary knowledge.
    Wolf DC; Cohen SM; Boobis AR; Dellarco VL; Fenner-Crisp PA; Moretto A; Pastoor TP; Schoeny RS; Seed JG; Doe JE
    Regul Toxicol Pharmacol; 2019 Apr; 103():86-92. PubMed ID: 30634023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Building an organ-specific carcinogenic database for SAR analyses.
    Young J; Tong W; Fang H; Xie Q; Pearce B; Hashemi R; Beger R; Cheeseman M; Chen J; Chang YC; Kodell R
    J Toxicol Environ Health A; 2004 Sep; 67(17):1363-89. PubMed ID: 15371237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of cell-cell interaction in tumor promotion].
    Yamasaki H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):773-81. PubMed ID: 3963844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis.
    Benigni R; Bossa C; Tcheremenskaia O
    Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.